Physician profile
Aaron Drapeau
NPI 1780152959
$255.59
in general payments reported to CMS, 2019-2025
10 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $42.67 | 2025 | Nucala |
| Novo Nordisk INC | $38.65 | 2025 | |
| Pfizer INC. | $28.21 | 2025 | |
| Boston Scientific Corporation | $26.74 | 2025 | Watchman Flx |
| Abbvie INC. | $25.48 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.72 | 2025 | Xifaxan |
| Amgen INC. | $19.97 | 2025 | Evenity |
| Dexcom, INC. | $19.44 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $18.76 | 2025 | Winrevair |
| Verona Pharma, INC. | $13.95 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Drapeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.